OOIR: Observatory of International Research

Papers

(The H4-Index of Epilepsia is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions	359
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions	338
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions	194
The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures	177
The SANTÉ study at 10 years of follow‐up: Effectiveness, safety, and sudden unexpected death in epilepsy	162
The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission	140
Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions	112
International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions	109
International consensus on diagnosis and management of Dravet syndrome	97
Epilepsy and brain network hubs	86
Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta‐analysis	86
Seizure detection using wearable sensors and machine learning: Setting a benchmark	76
Deep brain stimulation targets in epilepsy: Systematic review and meta‐analysis of anterior and centromedian thalamic nuclei and hippocampus	69
Genetic testing for the epilepsies: A systematic review	67
Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: A systematic review and meta‐analysis of outcomes	66
Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy	66
Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials	64
Pilot study of focused ultrasound for drug‐resistant epilepsy	61
Connectome biomarkers of drug‐resistant epilepsy	60
International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: Statements and supporting evidence	60
Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial	59
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress	56
Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial	56
Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial	53
Epilepsy care during the COVID‐19 pandemic	53

Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology	52
Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease	52
Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy	52
International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including febrile infection‐related epilepsy syndrome (FIRES): Summary and clinical tools	51
Cross talk between drug‐resistant epilepsy and the gut microbiome	50
Systematic review of frequency of felt and enacted stigma in epilepsy and determining factors and attitudes toward persons living with epilepsy—Report from the International League Against Epilepsy Ta	48
The global cost of epilepsy: A systematic review and extrapolation	48
Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial	46
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development	46
Neurostimulation in people with drug‐resistant epilepsy: Systematic review and meta‐analysis from the ILAE Surgical Therapies Commission	46
Accurate detection of typical absence seizures in adults and children using a two‐channel electroencephalographic wearable behind the ears	46
The severe epilepsy syndromes of infancy: A population‐based study	45
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study	45
Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial	44
Focal to bilateral tonic–clonic seizures are associated with widespread network abnormality in temporal lobe epilepsy	44
The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?	44
Seizure control, stress, and access to care during the COVID‐19 pandemic in New York City: The patient perspective	43
The worldwide epilepsy treatment gap: A systematic review and recommendations for revised definitions – A report from the ILAE Epidemiology Commission	43